This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other changes in lacrimal passages
H7_LACRIPAS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
52 |
4. Check minimum number of eventsNone |
52 |
5. Include endpointsNone |
52 |
6. Filter based on genotype QC (FinnGen only) |
47 |
Control definitions (FinnGen only)
- Control exclude
- H7_LIDLACRIMALORBIT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H04
- Name in latin
- Aliae morbositates apparati lacrimalis
Similar endpoints
↥List of similar endpoints to
Other changes in lacrimal passages
based on the number of shared cases.
Similar with more cases:
- Disorders of lacrimal system
- Disorders of eyelid, lacrimal system and orbit
- Diseases of the eye and adnexa
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 334 | 214 | 120 |
| Only index persons | 291 | 191 | 100 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | - | 54.59 | 38.23 |
| Only index persons | 49.58 | 54.40 | 40.38 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 47 | 40 | 7 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | 52.80 | 55.53 | 37.20 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 52
- Matched controls
- 520
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A98, ,
ICD-O-3
+∞
71.7
51
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
62.9
47
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
62.9
47
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
62.9
47
*
J01DB01, ,
ATC
cefalexin; oral
+∞
62.9
47
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
53.8
42
*
H046, ,
ICD-10 Finland
Other changes in lacrimal passages
+∞
52.1
41
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
48.9
39
*
M03BX02, ,
ATC
tizanidine; oral
+∞
47.3
38
*
SAA01, ,
ICD-O-3
+∞
44.2
36
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
44.2
36
*
WX110, ,
ICD-O-3
+∞
42.7
35
*
SAA02, ,
ICD-O-3
+∞
42.7
35
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
41.2
34
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
41.2
34
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
39.8
33
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
36.9
31
*
SFA20, ,
ICD-O-3
+∞
36.9
31
*
EB1AA, ,
ICD-O-3
+∞
36.9
31
*
K021, ,
ICD-O-3
+∞
34.2
29
*
KMAK, ,
ICD-O-3
+∞
34.2
29
*
J01DA01, ,
ATC
[U] cefalexin
+∞
32.8
28
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
32.8
28
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
32.8
28
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
32.8
28
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
32.8
28
*
R01AD09, ,
ATC
mometasone; nasal
+∞
31.5
27
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
31.5
27
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
31.5
27
*
R06AE07, ,
ATC
cetirizine; oral
+∞
30.1
26
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
30.1
26
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
30.1
26
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
30.1
26
*
SFA10, ,
ICD-O-3
+∞
30.1
26
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
28.8
25
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
28.8
25
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
27.5
24
*
GD1AA, ,
ICD-O-3
+∞
27.5
24
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
27.5
24
*
Z012, ,
ICD-O-3
+∞
27.5
24
*
J069, ,
ICD-O-3
+∞
27.5
24
*
S18, ,
ICD-O-3
+∞
27.5
24
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
26.3
23
*
EB1SA, ,
ICD-O-3
+∞
26.3
23
*
WZB00, ,
ICD-O-3
+∞
25.0
22
*
Z871, ,
ICD-O-3
+∞
25.0
22
*
ZXE00, ,
ICD-O-3
+∞
25.0
22
*
M796, ,
ICD-O-3
+∞
25.0
22
*
E0000UV, ,
ATC
+∞
25.0
22
*
K0364, ,
ICD-O-3
+∞
23.8
21
*
WYA05, ,
ICD-O-3
+∞
23.8
21
*
EB1HA, ,
ICD-O-3
+∞
23.8
21
*
L17, ,
ICD-O-3
+∞
23.8
21
*
SAA03, ,
ICD-O-3
+∞
23.8
21
*
SFA30, ,
ICD-O-3
+∞
23.8
21
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
23.8
21
*
R4110, ,
ICD-O-3
+∞
22.5
20
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
22.5
20
*
R05, ,
ICD-O-3
+∞
22.5
20
*
-1, ,
ICD-O-3
+∞
22.5
20
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
22.5
20
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
22.5
20
*
R74, ,
ICD-O-3
+∞
22.5
20
*
SDA03, ,
ICD-O-3
+∞
22.5
20
*
SDA01, ,
ICD-O-3
+∞
21.3
19
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
21.3
19
*
SPAT1263, ,
ICD-O-3
+∞
21.3
19
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
21.3
19
*
ZXA00, ,
ICD-O-3
+∞
21.3
19
*
I10, ,
ICD-O-3
+∞
21.3
19
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
21.3
19
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
21.3
19
*
M02AA07, ,
ATC
piroxicam; topical
+∞
20.1
18
*
CJE20, ,
ICD-O-3
+∞
20.1
18
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
20.1
18
*
ZXD10, ,
ICD-O-3
+∞
20.1
18
*
WX290, ,
ICD-O-3
+∞
18.9
17
*
ZXE10, ,
ICD-O-3
+∞
18.9
17
*
M255, ,
ICD-O-3
+∞
18.9
17
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
18.9
17
*
H251, ,
ICD-10 Finland
Senile nuclear cataract
+∞
18.9
17
*
Z2221, ,
ICD-O-3
+∞
18.9
17
*
Z760, ,
ICD-O-3
+∞
18.9
17
*
VALMI, ,
ICD-O-3
+∞
18.9
17
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
17.7
16
*
SDA02, ,
ICD-O-3
+∞
17.7
16
*
M545, ,
ICD-O-3
+∞
17.7
16
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
17.7
16
*
SPAT1325, ,
ICD-O-3
+∞
17.7
16
*
LC2BE, ,
ICD-O-3
+∞
17.7
16
*
D82, ,
ICD-O-3
+∞
17.7
16
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
17.7
16
*
D07AC13, ,
ATC
mometasone; topical
+∞
17.7
16
*
D07AC01, ,
ATC
betamethasone; topical
+∞
17.7
16
*
D19, ,
ICD-O-3
+∞
17.7
16
*
AA1AD, ,
ICD-O-3
+∞
17.7
16
*
ZXA05, ,
ICD-O-3
+∞
17.7
16
*
WX320, ,
ICD-O-3
+∞
17.7
16
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
17.7
16
*
M01AX05, ,
ATC
glucosamine; oral
+∞
16.5
15
*
SDE02, ,
ICD-O-3
+∞
16.5
15
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
16.5
15
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
16.5
15
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
16.5
15
*
S01GX01, ,
ATC
cromoglicic acid; ophthalmic
+∞
16.5
15
*
Z718, ,
ICD-O-3
+∞
16.5
15
*
SPAT1249, ,
ICD-O-3
+∞
16.5
15
*
M255, ,
ICD-10 Finland
Pain in joint
+∞
16.5
15
*
R53, ,
ICD-O-3
+∞
16.5
15
*
EBA00, ,
ICD-O-3
+∞
16.5
15
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
16.5
15
*
R104, ,
ICD-O-3
+∞
16.5
15
*
UJD10, ,
ICD-O-3
+∞
16.5
15
*
R42, ,
ICD-10 Finland
Dizziness and giddiness
+∞
16.5
15
*
WZC00, ,
ICD-O-3
+∞
16.5
15
*
C09CA06, ,
ATC
candesartan; oral
+∞
16.5
15
*
WX408, ,
ICD-O-3
+∞
15.3
14
*
SPAT1223, ,
ICD-O-3
+∞
15.3
14
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
15.3
14
*
H045, ,
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
+∞
15.3
14
*
WX404, ,
ICD-O-3
+∞
15.3
14
*
SPAT1253, ,
ICD-O-3
+∞
15.3
14
*
C08CA01, ,
ATC
amlodipine; oral
+∞
15.3
14
*
Z712, ,
ICD-O-3
+∞
15.3
14
*
A28, ,
ICD-O-3
+∞
15.3
14
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
15.3
14
*
ZXD05, ,
ICD-O-3
+∞
15.3
14
*
SPAT1310, ,
ICD-O-3
+∞
15.3
14
*
R103, ,
ICD-10 Finland
Pain localized to other parts of lower abdomen
+∞
15.3
14
*
R83, ,
ICD-O-3
+∞
15.3
14
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
15.3
14
*
SPAT1256, ,
ICD-O-3
+∞
15.3
14
*
A10BA02, ,
ATC
metformin; oral
+∞
15.3
14
*
L15, ,
ICD-O-3
+∞
15.3
14
*
SCA01, ,
ICD-O-3
+∞
14.2
13
*
E000001, ,
ATC
+∞
14.2
13
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
14.2
13
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
14.2
13
*
SFA40, ,
ICD-O-3
+∞
14.2
13
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
14.2
13
*
R03DC03, ,
ATC
montelukast; oral
+∞
14.2
13
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
14.2
13
*
SPAT1312, ,
ICD-O-3
+∞
14.2
13
*
N06AB04, ,
ATC
citalopram; systemic
+∞
14.2
13
*
Z017, ,
ICD-O-3
+∞
14.2
13
*
Z3226, ,
ICD-O-3
+∞
14.2
13
*
Z3231, ,
ICD-O-3
+∞
14.2
13
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
14.2
13
*
H02AB07, ,
ATC
prednisone; oral
+∞
14.2
13
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
14.2
13
*
OAB43, ,
ICD-O-3
+∞
14.2
13
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
13.0
12
*
N03AX12, ,
ATC
[U] gabapentin; oral
+∞
13.0
12
*
ZXA10, ,
ICD-O-3
+∞
13.0
12
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
13.0
12
*
SPAT1260, ,
ICD-O-3
+∞
13.0
12
*
L03, ,
ICD-O-3
+∞
13.0
12
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
13.0
12
*
R03BA02, ,
ATC
budesonide; inhalant
+∞
13.0
12
*
R06AE09, ,
ATC
levocetirizine; oral
+∞
13.0
12
*
N05CF01, ,
ATC
zopiclone; oral
+∞
13.0
12
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
13.0
12
*
J069, ,
ICD-10 Finland
Acute upper respiratory infection, unspecified
+∞
13.0
12
*
NG1AA, ,
ICD-O-3
+∞
13.0
12
*
M01AX17, ,
ATC
nimesulide; oral
+∞
13.0
12
*
N02AA05, ,
ATC
oxycodone; systemic
+∞
13.0
12
*
M03BC01, ,
ATC
orphenadrine (citrate); systemic
+∞
13.0
12
*
N05BA04, ,
ATC
oxazepam; oral
+∞
13.0
12
*
J209, ,
ICD-O-3
+∞
13.0
12
*
C03CA01, ,
ATC
furosemide; systemic
+∞
13.0
12
*
R5110, ,
ICD-O-3
+∞
13.0
12
*
K045, ,
ICD-O-3
+∞
13.0
12
*
SPAT1301, ,
ICD-O-3
+∞
13.0
12
*
J010, ,
ICD-O-3
+∞
13.0
12
*
C10AA01, ,
ATC
simvastatin; oral
+∞
13.0
12
*
L08, ,
ICD-O-3
+∞
11.9
11
*
J01MA06, ,
ATC
norfloxacin; oral
+∞
11.9
11
*
GD1UA, ,
ICD-O-3
+∞
11.9
11
*
WZA90, ,
ICD-O-3
+∞
11.9
11
*
M751, ,
ICD-O-3
+∞
11.9
11
*
K0365, ,
ICD-O-3
+∞
11.9
11
*
J459, ,
ICD-10 Finland
Asthma, unspecified
+∞
11.9
11
*
M171, ,
ICD-10 Finland
Other primary gonarthrosis
+∞
11.9
11
*
R06AX27, ,
ATC
desloratadine; oral
+∞
11.9
11
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
11.9
11
*
215, ,
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
11.9
11
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
11.9
11
*
F510, ,
ICD-O-3
+∞
11.9
11
*
R02, ,
ICD-O-3
+∞
11.9
11
*
R21, ,
ICD-O-3
+∞
11.9
11
*
WX402, ,
ICD-O-3
+∞
11.9
11
*
Z024, ,
ICD-O-3
+∞
11.9
11
*
K0382, ,
ICD-O-3
+∞
11.9
11
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
11.9
11
*
A03, ,
ICD-O-3
+∞
11.9
11
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
11.9
11
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
11.9
11
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
11.9
11
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
11.9
11
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
11.9
11
*
TPH04, ,
ICD-O-3
+∞
10.8
10
*
A01, ,
ICD-O-3
+∞
10.8
10
*
R06AX22, ,
ATC
ebastine; oral
+∞
10.8
10
*
D01, ,
ICD-O-3
+∞
10.8
10
*
D11, ,
ICD-O-3
+∞
10.8
10
*
NB1AA, ,
ICD-O-3
+∞
10.8
10
*
S21, ,
ICD-O-3
+∞
10.8
10
*
R03AC03, ,
ATC
terbutaline; inhalant
+∞
10.8
10
*
A09, ,
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
+∞
10.8
10
*
L13, ,
ICD-O-3
+∞
10.8
10
*
UJF32, ,
ICD-O-3
+∞
10.8
10
*
WX002, ,
ICD-O-3
+∞
10.8
10
*
M54, ,
ICD-O-3
+∞
10.8
10
*
D07AA02, ,
ATC
hydrocortisone; topical
+∞
10.8
10
*
F29, ,
ICD-O-3
+∞
10.8
10
*
SDE03, ,
ICD-O-3
+∞
10.8
10
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
10.8
10
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
10.8
10
*
R01AD01, ,
ATC
beclometasone; nasal
+∞
10.8
10
*
FM1EE, ,
ICD-O-3
+∞
10.8
10
*
M791, ,
ICD-O-3
+∞
10.8
10
*
D07AD01, ,
ATC
clobetasol; topical
+∞
10.8
10
*
M02AA10, ,
ATC
ketoprofen; topical
+∞
10.8
10
*
C07AA05, ,
ATC
propranolol; systemic
+∞
10.8
10
*
H100, ,
ICD-O-3
+∞
10.8
10
*
M01AG02, ,
ATC
tolfenamic acid; oral, rectal
+∞
10.8
10
*
SPAT1254, ,
ICD-O-3
+∞
9.7
9
*
H01, ,
ICD-O-3
+∞
9.7
9
*
NA3BG, ,
ICD-O-3
+∞
9.7
9
*
A97, ,
ICD-O-3
+∞
9.7
9
*
XF400, ,
ICD-O-3
+∞
9.7
9
*
WX105, ,
ICD-O-3
+∞
9.7
9
*
E039, ,
ICD-10 Finland
Hypothyroidism, unspecified
+∞
9.7
9
*
SPAT1250, ,
ICD-O-3
+∞
9.7
9
*
Z015, ,
ICD-10 Finland
Diagnostic skin and sensitization tests
+∞
9.7
9
*
R074, ,
ICD-O-3
+∞
9.7
9
*
XCC00, ,
ICD-O-3
+∞
9.7
9
*
H0410, ,
ICD-10 Finland
Dry eye syndrome
+∞
9.7
9
*
S29, ,
ICD-O-3
+∞
9.7
9
*
SFC01, ,
ICD-O-3
+∞
9.7
9
*
C09AA05, ,
ATC
ramipril; oral
+∞
9.7
9
*
AA1BG, ,
ICD-O-3
+∞
9.7
9
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
9.7
9
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
9.7
9
*
SFA00, ,
ICD-O-3
+∞
9.7
9
*
N03AX16, ,
ATC
[U] pregabalin
+∞
9.7
9
*
N300, ,
ICD-O-3
+∞
9.7
9
*
M751, ,
ICD-10 Finland
Rotator cuff syndrome
+∞
9.7
9
*
SPAT1306, ,
ICD-O-3
+∞
9.7
9
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
9.7
9
*
R06AX13, ,
ATC
loratadine; oral
+∞
9.7
9
*
C01DA08, ,
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
+∞
9.7
9
*
M232, ,
ICD-10 Finland
Derangement of meniscus due to old tear or injury
+∞
9.7
9
*
R101, ,
ICD-O-3
+∞
9.7
9
*
SDA04, ,
ICD-O-3
+∞
9.7
9
*
SPAT1283, ,
ICD-O-3
+∞
9.7
9
*
I251, ,
ICD-10 Finland
Atherosclerotic heart disease
+∞
9.7
9
*
JN3AD, ,
ICD-O-3
+∞
9.7
9
*
J01DA06, ,
ATC
[U] cefuroxime
+∞
9.7
9
*
J02AC02, ,
ATC
itraconazole; systemic
+∞
9.7
9
*
H438, ,
ICD-10 Finland
Other disorders of vitreous body
+∞
8.6
8
*
G01AA10, ,
ATC
clindamycin; vaginal
+∞
8.6
8
*
L309, ,
ICD-O-3
+∞
8.6
8
*
Z363, ,
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
+∞
8.6
8
*
H02AB04, ,
ATC
methylprednisolone; systemic
+∞
8.6
8
*
SPAT1153, ,
ICD-O-3
+∞
8.6
8
*
ND2AA, ,
ICD-O-3
+∞
8.6
8
*
A02BA02, ,
ATC
ranitidine; systemic
+∞
8.6
8
*
M01AH01, ,
ATC
celecoxib; oral
+∞
8.6
8
*
T90, ,
ICD-O-3
+∞
8.6
8
*
K020, ,
ICD-O-3
+∞
8.6
8
*
WX700, ,
ICD-O-3
+∞
8.6
8
*
C07AB02, ,
ATC
metoprolol; systemic
+∞
8.6
8
*
R529, ,
ICD-O-3
+∞
8.6
8
*
N05BA01, ,
ATC
diazepam; systemic, rectal
+∞
8.6
8
*
Z014, ,
ICD-O-3
+∞
8.6
8
*
R42, ,
ICD-O-3
+∞
8.6
8
*
H81, ,
ICD-O-3
+∞
8.6
8
*
L28, ,
ICD-O-3
+∞
8.6
8
*
R53, ,
ICD-10 Finland
Malaise and fatigue
+∞
8.6
8
*
R103, ,
ICD-O-3
+∞
8.6
8
*
FM1AE, ,
ICD-O-3
+∞
8.6
8
*
J01AA07, ,
ATC
tetracycline; systemic
+∞
8.6
8
*
FN1AC, ,
ICD-O-3
+∞
8.6
8
*
Z014, ,
ICD-10 Finland
Gynaecological examination (general)(routine)
+∞
8.6
8
*
SPAT1222, ,
ICD-O-3
+∞
8.6
8
*
L12, ,
ICD-O-3
+∞
8.6
8
*
A04, ,
ICD-O-3
+∞
8.6
8
*
G442, ,
ICD-O-3
+∞
8.6
8
*
N06AB03, ,
ATC
fluoxetine; oral
+∞
8.6
8
*
K573, ,
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
+∞
8.6
8
*
N05AH04, ,
ATC
quetiapine; oral
+∞
8.6
8
*
G03DA02, ,
ATC
medroxyprogesterone; systemic
+∞
8.6
8
*
T814, ,
ICD-10 Finland
Infection following a procedure, not elsewhere classified
+∞
8.6
8
*
E039, ,
ICD-O-3
+∞
8.6
8
*
J450, ,
ICD-10 Finland
Predominantly allergic asthma
+∞
8.6
8
*
R01AD58, ,
ATC
fluticasone, combinations; nasal
+∞
8.6
8
*
NH3AA, ,
ICD-O-3
+∞
8.6
8
*
C01DA14, ,
ATC
isosorbide mononitrate; oral
+∞
8.6
8
*
JN3AE, ,
ICD-O-3
+∞
8.6
8
*
C05AA08, ,
ATC
fluocortolone; rectal, topical
+∞
8.6
8
*
R101, ,
ICD-10 Finland
Pain localized to upper abdomen
+∞
8.6
8
*
WZC30, ,
ICD-O-3
+∞
8.6
8
*
N760, ,
ICD-O-3
+∞
8.6
8
*
3756X, ,
ICD-9 Finland
Disorders of lachrymal system, Other changes of lachrymal passages
+∞
7.5
7
*
M544, ,
ICD-O-3
+∞
7.5
7
*
B01AC04, ,
ATC
clopidogrel; oral
+∞
7.5
7
*
SPAT1053, ,
ICD-O-3
+∞
7.5
7
*
65000, ,
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
+∞
7.5
7
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
7.5
7
*
O800, ,
ICD-10 Finland
Spontaneous vertex delivery
+∞
7.5
7
*
104, ,
Kela drug reimbursment
Thyroid insufficiency
+∞
7.5
7
*
L11, ,
ICD-O-3
+∞
7.5
7
*
XLD00, ,
ICD-O-3
+∞
7.5
7
*
F3210, ,
ICD-10 Finland
Moderate depressive episode without somatic syndrome
+∞
7.5
7
*
C09CA01, ,
ATC
losartan; oral
+∞
7.5
7
*
N05CD07, ,
ATC
temazepam; oral
+∞
7.5
7
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
7.5
7
*
JN1AE, ,
ICD-O-3
+∞
7.5
7
*
P20, ,
ICD-O-3
+∞
7.5
7
*
MA2HE, ,
ICD-O-3
+∞
7.5
7
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
7.5
7
*
290, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
7.5
7
*
SPAT1262, ,
ICD-O-3
+∞
7.5
7
*
SPAT1216, ,
ICD-O-3
+∞
7.5
7
*
N950, ,
ICD-10 Finland
Postmenopausal bleeding
+∞
7.5
7
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
7.5
7
*
R238, ,
ICD-O-3
+∞
7.5
7
*
I48, ,
ICD-10 Finland
Atrial fibrillation and flutter
+∞
7.5
7
*
N390, ,
ICD-10 Finland
Urinary tract infection, site not specified
+∞
7.5
7
*
R5180, ,
ICD-10 Finland
Headache
+∞
7.5
7
*
LCA06, ,
ICD-O-3
+∞
7.5
7
*
WX100, ,
ICD-O-3
+∞
7.5
7
*
N05CF02, ,
ATC
zolpidem; oral
+∞
7.5
7
*
G01AF05, ,
ATC
econazole; vaginal
+∞
7.5
7
*
B01AA03, ,
ATC
warfarin; systemic
+∞
7.5
7
*
JN3BD, ,
ICD-O-3
+∞
7.5
7
*
XCW99, ,
ICD-O-3
+∞
7.5
7
*
N390, ,
ICD-O-3
+∞
7.5
7
*
S82, ,
ICD-O-3
+∞
7.5
7
*
QAE10, ,
ICD-O-3
+∞
7.5
7
*
E000002, ,
ATC
+∞
7.5
7
*
C03EA01, ,
ATC
hydrochlorothiazide and potassium-sparing agents; oral
+∞
7.5
7
*
N01, ,
ICD-O-3
+∞
7.5
7
*
WYA10, ,
ICD-O-3
+∞
7.5
7
*
N02AE01, ,
ATC
buprenorphine; parenteral, sublingual, transdermal
+∞
7.5
7
*
S060, ,
ICD-10 Finland
Concussion
+∞
7.5
7
*
N06AX21, ,
ATC
duloxetine; oral
+∞
7.5
7
*
M480, ,
ICD-10 Finland
Spinal stenosis
+∞
7.5
7
*
351, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
7.5
7
*
U02, ,
ICD-O-3
+∞
7.5
7
*
UKC02, ,
ICD-O-3
+∞
7.5
7
*
E119, ,
ICD-O-3
+∞
7.5
7
*
GD1QA, ,
ICD-O-3
+∞
7.5
7
*
Z258, ,
ICD-O-3
+∞
7.5
7
*
NA1AD, ,
ICD-O-3
+∞
7.5
7
*
M531, ,
ICD-O-3
+∞
7.5
7
*
B02AA02, ,
ATC
tranexamic acid; systemic
+∞
7.5
7
*
N06AX16, ,
ATC
venlafaxine; oral
+∞
7.5
7
*
WW200, ,
ICD-O-3
+∞
7.5
7
*
D01BA02, ,
ATC
terbinafine; oral
+∞
7.5
7
*
R13, ,
ICD-10 Finland
Dysphagia
+∞
6.4
6
*
Z961, ,
ICD-10 Finland
Presence of intraocular lens
+∞
6.4
6
*
114, ,
Kela drug reimbursment
Glaucoma
+∞
6.4
6
*
UJF30, ,
ICD-O-3
+∞
6.4
6
*
PH2AE, ,
ICD-O-3
+∞
6.4
6
*
L02, ,
ICD-O-3
+∞
6.4
6
*
H660, ,
ICD-O-3
+∞
6.4
6
*
M02AA15, ,
ATC
diclofenac; topical
+∞
6.4
6
*
H264, ,
ICD-10 Finland
After-cataract
+∞
6.4
6
*
R03AK06, ,
ATC
salmeterol and fluticasone; inhalant
+∞
6.4
6
*
M17, ,
ICD-O-3
+∞
6.4
6
*
Z016, ,
ICD-O-3
+∞
6.4
6
*
B01AF02, ,
ATC
apixaban; oral
+∞
6.4
6
*
J05AB11, ,
ATC
valaciclovir; oral
+∞
6.4
6
*
A09, ,
ICD-O-3
+∞
6.4
6
*
J20, ,
ICD-O-3
+∞
6.4
6
*
K0510, ,
ICD-O-3
+∞
6.4
6
*
OAA65, ,
ICD-O-3
+∞
6.4
6
*
M161, ,
ICD-10 Finland
Other primary coxarthrosis
+∞
6.4
6
*
A01AB09, ,
ATC
miconazole; local oral
+∞
6.4
6
*
B01AF01, ,
ATC
rivaroxaban; oral
+∞
6.4
6
*
I839, ,
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
+∞
6.4
6
*
R03BA08, ,
ATC
ciclesonide; inhalant
+∞
6.4
6
*
J189, ,
ICD-O-3
+∞
6.4
6
*
L84, ,
ICD-O-3
+∞
6.4
6
*
R03BA01, ,
ATC
beclometasone; inhalant
+∞
6.4
6
*
H045, ,
ICD-O-3
+∞
6.4
6
*
J320, ,
ICD-10 Finland
Chronic maxillary sinusitis
+∞
6.4
6
*
C01DA02, ,
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
+∞
6.4
6
*
SPAT1230, ,
ICD-O-3
+∞
6.4
6
*
R55, ,
ICD-10 Finland
Syncope and collapse
+∞
6.4
6
*
SCA02, ,
ICD-O-3
+∞
6.4
6
*
H109, ,
ICD-O-3
+∞
6.4
6
*
E7801, ,
ICD-O-3
+∞
6.4
6
*
N06AB10, ,
ATC
escitalopram; oral
+∞
6.4
6
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
6.4
6
*
SPAT1211, ,
ICD-O-3
+∞
6.4
6
*
D07CA01, ,
ATC
hydrocortisone and antibiotics; topical
+∞
6.4
6
*
ULA02, ,
ICD-O-3
+∞
6.4
6
*
AN1, ,
ICD-O-3
+∞
6.4
6
*
SPAT1292, ,
ICD-O-3
+∞
6.4
6
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
6.4
6
*
202, ,
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
+∞
6.4
6
*
G560, ,
ICD-10 Finland
Carpal tunnel syndrome
+∞
6.4
6
*
F419, ,
ICD-O-3
+∞
6.4
6
*
NE1AA, ,
ICD-O-3
+∞
6.4
6
*
N10, ,
ICD-10 Finland
Acute tubulo-interstitial nephritis
+∞
6.4
6
*
N02CC01, ,
ATC
sumatriptan; nasal, systemic, rectal
+∞
6.4
6
*
M706, ,
ICD-O-3
+∞
6.4
6
*
R01AD11, ,
ATC
triamcinolone; nasal
+∞
6.4
6
*
J019, ,
ICD-O-3
+∞
6.4
6
*
M545, ,
ICD-10 Finland
Low back pain
+∞
6.4
6
*
NGD05, ,
ICD-O-3
+∞
6.4
6
*
R298, ,
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
+∞
6.4
6
*
J010, ,
ICD-10 Finland
Acute maxillary sinusitis
+∞
6.4
6
*
ND1AA, ,
ICD-O-3
+∞
6.4
6
*
NF1AA, ,
ICD-O-3
+∞
6.4
6
*
MA2AE, ,
ICD-O-3
+∞
6.4
6
*
A23, ,
ICD-O-3
+∞
6.4
6
*
L01, ,
ICD-O-3
+∞
6.4
6
*
E11, ,
ICD-O-3
+∞
6.4
6
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
6.4
6
*
W17, ,
ICD-10 Finland
Other fall from one level to another
+∞
6.4
6
*
G473, ,
ICD-O-3
+∞
6.4
6
*
D06BX01, ,
ATC
metronidazole; topical
+∞
6.4
6
*
L82, ,
ICD-O-3
+∞
6.4
6
*
M01AH03, ,
ATC
valdecoxib; oral
+∞
6.4
6
*
SPAT1324, ,
ICD-O-3
+∞
6.4
6
*
Z004, ,
ICD-10 Finland
General psychiatric examination, not elsewhere classified
+∞
6.4
6
*
M190, ,
ICD-10 Finland
Primary arthrosis of other joints
+∞
6.4
6
*
H0410, ,
ICD-O-3
+∞
6.4
6
*
U071, ,
ICD-O-3
+∞
6.4
6
*
M179, ,
ICD-O-3
+∞
6.4
6
*
G03DB01, ,
ATC
dydrogesterone; oral
+∞
6.4
6
*
NA1BG, ,
ICD-O-3
+∞
6.4
6
*
C10AX09, ,
ATC
ezetimibe; oral
+∞
6.4
6
*
G03FB06, ,
ATC
medroxyprogesterone and estrogen; systemic
+∞
6.4
6
*
KH1AE, ,
ICD-O-3
+∞
6.4
6
*
DM1QA, ,
ICD-O-3
+∞
6.4
6
*
P01, ,
ICD-O-3
+∞
6.4
6
*
JKA21, ,
ICD-O-3
+∞
6.4
6
*
EBA05, ,
ICD-O-3
+∞
6.4
6
*
M190, ,
ICD-O-3
+∞
6.4
6
*
Z008, ,
ICD-O-3
+∞
6.4
6
*
A10AE04, ,
ATC
insulin glargine; parenteral
+∞
6.4
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
8
18
5.05
2.93
1.9
1.3
—
—
—
0
0
7
15
5.21
2.70
3.1
1.9
2.64
3.31
g/l
—
7
15
38
259
2.74
2.65
11.8
9.8
4.46
4.05
e9/l
0.43
33
226
23
124
2.53
2.63
5.5
3.0
0.12
0.19
e6/l
0.23
18
88
7
16
4.88
2.57
3.1
1.8
—
—
—
0
0
7
16
4.88
2.57
3.1
1.8
7.27
8.04
g/l
—
7
16
7
16
4.88
2.57
3.1
1.8
3.03
3.82
g/l
—
7
16
25
142
2.46
2.54
3.8
2.7
26.00
28.86
u/l
0.59
25
134
7
17
4.58
2.45
2.0
1.2
—
—
—
0
0
16
75
2.64
2.39
2.8
2.8
8.64
41.33
ng/l
1.50
11
54
17
84
2.52
2.28
2.1
1.5
—
—
—
0
0
16
78
2.52
2.20
4.5
2.5
1.44
0.63
e6/l
—
9
43
25
151
2.26
2.13
6.5
2.9
—
—
—
0
0
43
336
2.61
2.07
5.0
4.0
12.56
12.11
mm/h
0.10
43
302
31
208
2.21
2.01
9.1
5.1
0.00
0.00
estimate
—
7
44
6
16
4.09
2.00
3.5
1.8
10.05
10.37
g/l
—
6
16
9
35
2.89
1.91
2.8
2.3
6.28
5.66
kpa
—
9
35
37
271
2.27
1.88
3.5
2.7
41.38
45.73
u/l
0.18
37
252
31
212
2.14
1.87
6.8
3.6
0.00
0.00
estimate
—
7
46
31
213
2.13
1.84
6.8
3.6
0.00
0.00
estimate
—
7
43
28
186
2.09
1.81
12.8
10.4
1.37
1.24
inr
—
6
68
6
18
3.62
1.80
1.5
2.1
24.47
24.28
mmol/l
—
6
18
47
397
2.91
1.65
24.8
15.8
15.58
14.79
%
0.32
47
389
5
15
3.57
1.56
3.0
1.9
38.90
38.01
g/l
—
5
15
5
15
3.57
1.56
2.8
1.9
0.00
0.00
g/l
—
5
15
16
90
2.12
1.55
1.3
1.3
26.90
31.44
iu/ml
—
5
37
6
23
2.81
1.41
2.2
1.2
—
—
—
0
0
14
78
2.09
1.38
5.1
2.5
0.86
2.60
e6/l
—
7
43
31
230
1.86
1.32
6.3
6.4
10.65
9.41
umol/l
0.45
31
214
46
397
2.37
1.26
6.4
5.0
40.00
39.13
mmol/mol
0.23
46
366
20
132
1.84
1.21
3.6
2.1
87.20
137.79
u/l
0.81
20
123
24
173
1.72
1.06
2.3
1.8
107.19
100.88
pmol/l
—
9
78
46
408
2.10
0.98
19.1
12.8
84.06
82.30
ml/min/173m2
0.21
40
323
10
57
1.93
0.91
1.8
2.4
2.60
2.52
g/l
—
10
48
26
205
1.54
0.74
5.7
5.5
1.21
1.23
mmol/l
0.98
20
171
25
196
1.53
0.73
3.6
2.6
195.81
74.60
ug/l
0.61
25
180
13
90
1.59
0.63
1.2
1.3
1.24
11.31
u/ml
—
7
35
6
40
1.56
0.53
4.7
3.7
102.17
102.65
mmol/l
—
6
40
15
112
1.48
0.52
2.7
2.5
303.27
3800.37
umol/l
0.50
15
93
20
160
1.41
0.49
7.8
3.7
13.22
58.44
ng/l
0.99
12
109
33
289
1.39
0.46
3.9
3.4
—
—
—
0
0
0
17
0.00
0.41
0.0
1.7
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
5
35
1.47
0.40
2.2
1.9
—
—
—
0
0
6
45
1.38
0.35
3.0
1.4
—
—
—
0
0
14
111
1.36
0.34
9.1
3.9
0.00
0.00
estimate
—
7
44
20
171
1.28
0.29
7.9
3.4
—
—
—
0
0
5
40
1.28
0.23
1.2
1.6
—
—
—
0
0
5
40
1.28
0.23
4.8
4.0
5.32
5.25
kpa
—
5
40
0
11
0.00
0.21
0.0
3.5
—
26.61
—
0
11
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
4.50
—
0
6
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
1.26
—
0
5
24
216
1.21
0.21
3.0
2.3
—
—
—
0
0
7
62
1.15
0.18
2.6
2.0
—
—
—
0
0
8
68
1.21
0.18
2.5
1.6
—
—
—
0
0
10
84
1.24
0.15
3.8
1.9
—
—
—
0
0
5
45
1.12
0.10
12.2
4.4
—
—
—
0
0
5
45
1.12
0.10
3.2
1.3
—
—
—
0
0
5
46
1.10
0.10
19.0
7.3
—
—
—
0
0
11
97
1.17
0.10
1.5
1.4
—
—
—
0
0
6
56
1.08
0.09
1.8
1.8
—
—
—
0
0
11
108
1.02
0.00
2.0
1.5
12.46
24.02
nmol/l
3.60
11
86
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
7.50
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
26.04
—
0
7
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
9
93
0.96
-0.00
2.9
1.6
1484.00
1156.42
nmol/l
—
9
72
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
17.42
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
14.08
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint H7_LACRIPAS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have H7_LACRIPAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: H7_LACRIPAS – Other changes in lacrimal passages
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data